News

Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale

The latest people news happenings over the past month

The biggest areas of adjustment in patient support brought on by changes in consumer and physician behavior

The Discovery Centre will be powered by AI technology, robotics, among other features

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension

Approval is for the 50-µg dosage

Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally

ConvergeHEALTH Safety intended to automate pharmacovigilance case processing

Separation process expected to be completed in 18-24 months

White House announces official endorsement, paving way for Senate confirmation process

It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates

Expansion expected to more than double the plant’s footprint

PBM fees and vertical integration are also at the top of the list

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Partnership further increases investment firm’s repertoire in healthcare space

Boston area facility will focus heavily on cold chain services

Parties expect improved design and selection of eCOAs in decentralized clinical trials

Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints

Centers for Disease Control and Prevention endorses Pfizer-BioNTech jab, less than two months after firms presented positive study results

Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023

ScriptDrop, Adheris Health collaborate to assist patients with their medication regimens

Anticipated capacity of GMP facility is 60 million vials per year

A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022